Strategic Acquisition Opportunity Blacktrace was acquired by Unchained Labs in July 2023, signaling potential integration needs or collaboration opportunities with a larger life sciences platform to accelerate go-to-market, distribution leverage, or cross-sell of Productizing Science capabilities.

Microfluidics Expansion With Dolomite Microfluidics and Particle Works under the Blacktrace umbrella, there is a strong foothold in microfluidics and nanostructured materials—prime for partnerships with biopharma, diagnostics, or materials science firms seeking advanced prototyping, process development, or high-throughput single-cell workflows.

Global Reach and Partners Sales offices in the USA, Japan, and Vietnam plus 40+ distributors create a broad geographic network poised for channel partnerships, co-marketing initiatives, and regionalized support agreements to accelerate international revenue and reduce sales cycle.

Growth Hiring Window Ongoing growth and multiple open roles across science, commercial, and support functions offer an opportunity to propose scale-up collaborations, joint marketing ventures, or client onboarding programs to rapidly expand into new accounts.

Engineering to Solutions Productizing Science focus combined with a strong tech stack and premium scientific products suggests a fit for customers seeking end-to-end solutions—from discovery through commercialization—making cross-sell of Dolomite Bio, Dolomite Microfluidics, and Particle Works appealing to labs aiming to streamline workflows.